Systematic review of the incidence and prevalence of genital warts

H Patel, M Wagner, P Singhal, S Kothari - BMC infectious diseases, 2013 - Springer
Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

[HTML][HTML] Genital warts: a comprehensive review

VR Yanofsky, RV Patel… - The Journal of clinical and …, 2012 - ncbi.nlm.nih.gov
External genital warts, also known as condylomata acuminata, are extremely common, with
between 500,000 to one million new cases diagnosed each year in the United States alone …

Economic evaluation of human papillomavirus vaccination in the United Kingdom

M Jit, YH Choi, WJ Edmunds - Bmj, 2008 - bmj.com
Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …

Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts

G Gross, H Pfister - Medical microbiology and immunology, 2004 - Springer
Using PCR, the overall prevalence of human papillomavirus (HPV) DNA in penile carcinoma
is about 40–45%, which is similar to the detection rate of HPV-DNA in vulvar carcinoma …

Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of …

PV Chin‐Hong, GE Reid… - Clinical …, 2019 - Wiley Online Library
These guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice update the epidemiology and management of human papillomavirus …

[HTML][HTML] Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008)

S Hilton, K Hunt, M Langan, H Bedford… - Social science & …, 2010 - Elsevier
In September 2008, the human papillomavirus (HPV) immunisation programme was
introduced in the UK for schoolgirls aged between 12 and 18 years of age. The vaccine …

Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom

YH Choi, M Jit, N Gay, A Cox, GP Garnett, WJ Edmunds - Vaccine, 2010 - Elsevier
Many countries are considering vaccination against human papillomavirus (HPV). However,
the long-term impact of vaccination is difficult to predict due to uncertainty about the …

[HTML][HTML] Clinical and pathological aspects of condyloma acuminatum–review of literature and case presentation

D Diţescu, AM Istrate-Ofiţeru, GC Roşu… - Romanian Journal of …, 2021 - ncbi.nlm.nih.gov
Condyloma acuminatum (CA) is a pathology caused by the human papillomavirus (HPV). It
is manifested by the appearance of warts in the vulvar, pubic, and anorectal regions, but can …

Patients with LR-HPV infection have a distinct vaginal microbiota in comparison with healthy controls

Y Zhou, L Wang, F Pei, M Ji, F Zhang, Y Sun… - Frontiers in cellular …, 2019 - frontiersin.org
Condyloma acuminatum (CA) is a benign epithelium hyperplasia mainly caused by human
papillomavirus (HPV), which is now the second most common viral sexually transmitted …

School nurses' experiences of delivering the UK HPV vaccination programme in its first year

S Hilton, K Hunt, H Bedford, M Petticrew - BMC infectious diseases, 2011 - Springer
Abstract Background In the United Kingdom (UK) in September 2008, school nurses began
delivering the HPV immunisation programme for girls aged 12 and 13 years old. This study …